WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/026776    International Application No.:    PCT/AU1994/000254
Publication Date: 24.11.1994 International Filing Date: 18.05.1994
Chapter 2 Demand Filed:    15.12.1994    
A61K 38/00 (2006.01), A61K 39/00 (2006.01), C07K 14/16 (2006.01)
Applicants: BIOMOLECULAR RESEARCH INSTITUTE LTD. [AU/AU]; 343 Royal Parade, Parkville, VIC 3052 (AU) (For All Designated States Except US).
MACFARLANE BURNET CENTRE FOR MEDICAL RESEARCH LTD. [AU/AU]; Fairfield Hospital, Yarra Bend Road, Fairfield, VIC 3078 (AU) (For All Designated States Except US).
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION [AU/AU]; Limestone Avenue, Campbell, ACT 2601 (AU) (For All Designated States Except US).
AZAD, Ahmed, Abdullah [AU/AU]; (AU) (For US Only).
CURTAIN, Cyril, C. [AU/AU]; (AU) (For US Only).
GREENWAY, Alison, Louise [AU/AU]; (AU) (For US Only).
McPHEE, Dale, Alan [AU/AU]; (AU) (For US Only).
MACREADIE, Ian [AU/AU]; (AU) (For US Only)
Inventors: AZAD, Ahmed, Abdullah; (AU).
CURTAIN, Cyril, C.; (AU).
GREENWAY, Alison, Louise; (AU).
McPHEE, Dale, Alan; (AU).
Agent: SANTER, Vivien; Griffith Hack & Co., 509 St. Kilda Road, Melbourne, VIC 3004 (AU)
Priority Data:
PL 8861 18.05.1993 AU
Abstract: front page image
(EN)The invention relates to a biologically-active peptide fragment of the Nef protein of human immunodeficiency virus, to pharmaceutical compositions comprising these peptides or biologically-active analogues thereof, to antagonists of the peptides and to pharmaceutical compositions comprising these antagonists, and to therapeutic and screening methods utilising compounds and compositions of the invention.
(FR)L'invention porte sur des fragments peptidiques biologiquement actifs de la protéine Nef du virus de l'immunodéficience humaine, sur des préparations pharmaceutiques comportant ces peptides ou leurs analogues biologiquement actifs, sur des antagonistes desdits peptides, sur des préparations pharmaceutiques comportant lesdits antagonistes et sur des méthodes de thérapie et de dépistage utilisant les composés et préparations objets de cette invention.
Designated States: AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, ES, FI, GB, GE, HU, JP, KG, KP, KR, KZ, LK, LU, LV, MD, MG, MN, MW, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SI, SK, TJ, TT, UA, US, UZ, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)